U.S., Nov. 26 -- ClinicalTrials.gov registry received information related to the study (NCT07247279) titled 'Epidemiological Study of Treatment Approaches in AChR-Antibody Positive Generalized Myasthenia Gravis in Russia' on Nov. 18.

Brief Summary: This is a multicenter, non-interventional, retrospective-prospective, single-arm observational study designed to describe real-world treatment approaches and clinical outcomes among adults with acetylcholine receptor (AChR) antibody-positive generalized myasthenia gravis (gMG) in routine clinical practice in Russia.

Study Start Date: Dec. 31

Study Type: OBSERVATIONAL

Condition: Rare Diseases Generalized Myasthenia Gravis (gMG)

Recruitment Status: NOT_YET_RECRUITING

Sponsor: AstraZeneca

Di...